AR207765A1 - Procedimiento para la fabricacion de analogos de la deaminovasopresina con un puente disulfuro modificado - Google Patents

Procedimiento para la fabricacion de analogos de la deaminovasopresina con un puente disulfuro modificado

Info

Publication number
AR207765A1
AR207765A1 AR256291A AR25629174A AR207765A1 AR 207765 A1 AR207765 A1 AR 207765A1 AR 256291 A AR256291 A AR 256291A AR 25629174 A AR25629174 A AR 25629174A AR 207765 A1 AR207765 A1 AR 207765A1
Authority
AR
Argentina
Prior art keywords
deaminovasopresin
analogs
procedure
manufacture
disulfide bridge
Prior art date
Application number
AR256291A
Other languages
English (en)
Spanish (es)
Original Assignee
Ceskoslovenska Akademie Ved
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceskoslovenska Akademie Ved filed Critical Ceskoslovenska Akademie Ved
Application granted granted Critical
Publication of AR207765A1 publication Critical patent/AR207765A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AR256291A 1973-11-09 1974-01-01 Procedimiento para la fabricacion de analogos de la deaminovasopresina con un puente disulfuro modificado AR207765A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS7700A CS171787B1 (fr) 1973-11-09 1973-11-09

Publications (1)

Publication Number Publication Date
AR207765A1 true AR207765A1 (es) 1976-10-29

Family

ID=5426587

Family Applications (1)

Application Number Title Priority Date Filing Date
AR256291A AR207765A1 (es) 1973-11-09 1974-01-01 Procedimiento para la fabricacion de analogos de la deaminovasopresina con un puente disulfuro modificado

Country Status (15)

Country Link
US (1) US3980631A (fr)
JP (1) JPS5411319B2 (fr)
AR (1) AR207765A1 (fr)
BE (1) BE822062A (fr)
CA (1) CA1020547A (fr)
CH (1) CH610879A5 (fr)
CS (1) CS171787B1 (fr)
DE (1) DE2452279A1 (fr)
DK (1) DK567474A (fr)
FR (1) FR2250751B1 (fr)
GB (1) GB1440859A (fr)
IN (1) IN140167B (fr)
IT (1) IT1056739B (fr)
NL (1) NL7414490A (fr)
SE (1) SE419753B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235881A (en) * 1978-12-04 1980-11-25 Cort Joseph H Method for producing high potency factor VIII
US4285858A (en) * 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure
US4829051A (en) * 1983-04-05 1989-05-09 Vega Laboratories, Inc. N-substituted derivatives of 1-desaminovasopressin
US4483794A (en) * 1983-05-10 1984-11-20 Ceskoslovenska Akademie Ved Analogs of neurohypophysial hormones
US4551445A (en) * 1983-10-14 1985-11-05 The Medical College Of Ohio Derivatives of arginine vasopressin antagonists
US4714696A (en) * 1984-01-26 1987-12-22 Medical College Of Ohio Novel derivatives of arginine vasopressin antagonists
IE58407B1 (en) * 1984-04-13 1993-09-22 Akzo Nv Peptides
US4760052A (en) * 1986-01-16 1988-07-26 Smithkline Beckman Corporation 1,6-dicarba-vasopressin compounds
EP0300036A4 (fr) * 1987-01-30 1989-06-14 Biomed Res Consultants Ltd Compositions pharmaceutiques a base de vasopressine.
US4786631A (en) * 1988-03-18 1988-11-22 University Of Florida Novel arginine vasopressin-binding peptides
US6028168A (en) 1991-08-09 2000-02-22 Winfried Kolbeck Lanthionine bridged peptides
AU2237095A (en) * 1994-04-01 1995-10-23 Arcturus Pharmaceutical Corporation Method for delivering biologically active materials using a thioester or thioether prodrug
US5562812A (en) * 1995-04-03 1996-10-08 The Penn State Research Foundation Free flow electrophoresis device for biomolecule purification and separation in zero and one G
WO2010075266A2 (fr) 2008-12-22 2010-07-01 Serenity Pharmaceuticals Corporation Administration sécurisée de desmopressine
WO2010075327A1 (fr) * 2008-12-22 2010-07-01 Serenity Pharmaceuticals Corporation Composition de desmopressine
RU2015144851A (ru) 2009-06-18 2019-01-10 Серенити Фармасьютикалз, Элэлси Безопасное применение десмопрессина

Also Published As

Publication number Publication date
NL7414490A (nl) 1975-05-13
IT1056739B (it) 1982-02-20
SE7411817L (fr) 1975-05-12
CA1020547A (fr) 1977-11-08
DE2452279A1 (de) 1975-05-15
CS171787B1 (fr) 1976-11-29
CH610879A5 (fr) 1979-05-15
BE822062A (fr) 1975-03-03
FR2250751A1 (fr) 1975-06-06
JPS5411319B2 (fr) 1979-05-14
JPS5088085A (fr) 1975-07-15
US3980631A (en) 1976-09-14
DK567474A (fr) 1975-07-07
SE419753B (sv) 1981-08-24
GB1440859A (en) 1976-06-30
IN140167B (fr) 1976-09-25
FR2250751B1 (fr) 1979-05-11

Similar Documents

Publication Publication Date Title
AR208179A1 (es) Procedimiento para la produccion de (omega-1)-oxoalquildialquilxantinas
AR207877A1 (es) Procedimiento para la produccion de trasplantes heterologos de arterias
AR207765A1 (es) Procedimiento para la fabricacion de analogos de la deaminovasopresina con un puente disulfuro modificado
AR204928A1 (es) Procedimiento para la preparacion de(alquil-tioalquil)tioureas heterociclicas
AR199337A1 (es) Procedimiento para la preparacion de un elastomero de copolieterester termoplastico segmentado
AR201323A1 (es) Procedimiento para la produccion de un latex de policloropreno-alcohol polivinilico
AR207586A1 (es) Procedimiento para la produccion de nuevas cefalosporinas
AR209622A1 (es) Procedimiento para la fabricacion de fosgeno
AR200549A1 (es) Procedimiento para la fabricacion de gelatina modificada
AR204859A1 (es) Procedimiento para la produccion de 2-nitrobenzaldehido
AR208679A1 (es) Un procedimiento para la preparacion de compuestos de 7-beta-acilamido-7 alfa-metoxicefalosporina
AR197080A1 (es) Procedimiento para la produccion de un compuesto de tiourea
MX144222A (es) Procedimiento mejorado para la produccion de anhidrita
AR206658A1 (es) Procedimiento para la produccion de nuevos diariloxi-imidazolilacetales
AR207450A1 (es) Procedimiento para la produccion de derivados de 4-fenilsulfonil-metil-prehidroindan-5-onas
AR200171A1 (es) Procedimiento para la produccion de nuevas benzoilfenilguanidinas
AR228123A1 (es) Procedimiento para la produccion de halogenoacilamidas
AR207141A1 (es) Procedimiento para la produccion de 2-nitrobenzaldehido
AR203647A1 (es) Procedimiento para la elaboracion de acidos trialcoxibenzoilaminocarboxilicos conteniendo azufre
AR212907A1 (es) Procedimiento para la preparacion de un medicamento
AR214305A1 (es) Procedimiento para la produccion de n-acetiltienamicina
AR205708A1 (es) Un procedimiento para la preparacion de omega-nitroacetofenonas
AR209283A1 (es) Un procedimiento para la preparacion de un cefem
AR209316A1 (es) Procedimiento para la fabricacion de tetramisol
AR213076A1 (es) Procedimiento para la produccion de derivados de la glicilglicilanilida sustituida